-
-
-
-
Sequence Name
- Sequence 31 from Patent US 20110159022
-
Source
- Synthetic construct
-
-
-
Patent Type
- Patent Application
-
Publication Date
- 2011-6-30
-
-
Patent Title
- Immunogenic Peptides Derived from the Midkine Protein, as an Anticancer Vaccine.
-
Abstract
- A peptide derived from the Midkine protein, comprising at least one CD4+ T or CD8+ T epitope restricted by the HLA molecules predominant in the Caucasian population, or a polynucleotide encoding said peptide, as an anticancer vaccine or as a reagent for immunomonitoring of the cellular response against Midkine over the course of a cancer or of an anticancer treatment.